End Cash: The amount of cash held by the company for the given period.
Bolt Biotherapeutics, Inc. (BOLT) had End Cash of $13.44M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$2.50M |
|
$-6.63M |
|
-- |
|
$2.50M |
|
$9.59M |
|
$-7.08M |
|
$0.45M |
|
$-6.63M |
|
$-6.63M |
|
$-6.63M |
|
$-6.63M |
|
$-6.63M |
|
$-6.63M |
|
$-7.08M |
|
$-6.99M |
|
1.87M |
|
1.87M |
|
$-3.87 |
|
$-3.87 |
|
| Balance Sheet Financials | |
$30.26M |
|
$1.25M |
|
$26.49M |
|
$56.75M |
|
$8.44M |
|
$20.13M |
|
$21.81M |
|
$30.24M |
|
$26.50M |
|
$26.50M |
|
$26.50M |
|
1.92M |
|
| Cash Flow Statement Financials | |
$-39.85M |
|
$44.30M |
|
$0.02M |
|
$8.97M |
|
|
End Cash |
$13.44M |
$4.47M |
|
$2.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.59 |
|
-- |
|
-- |
|
0.43 |
|
0.76 |
|
100.00% |
|
-283.40% |
|
-283.40% |
|
-- |
|
-265.24% |
|
-265.24% |
|
$-38.96M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-25.02% |
|
-25.02% |
|
-11.69% |
|
-14.22% |
|
$13.80 |
|
$-20.83 |
|
$-21.31 |
|